Puberty is a complex developmental event, controlled by sophisticated regulatory networks that integrate peripheral and internal cues and impinge at the brain centers driving the reproductive axis. The tempo of puberty is genetically determined but is also sensitive to numerous modifiers, from metabolic and sex steroid signals to environmental factors. Recent epidemiological evidence suggests that the onset of puberty is advancing in humans, through as yet unknown mechanisms. In fact, while much knowledge has been gleaned recently on the mechanisms responsible for the control of mammalian puberty, fundamental questions regarding the intimate molecular and neuroendocrine pathways responsible for the precise timing of puberty and its deviations remain unsolved.
Introduction

Neurobiology of puberty: what we know, what we do not and why we should care
In complex organisms, intricate developmental programs occur allowing transition from immature to mature stages; the latter being defined by the acquisition of full reproductive capacity. In mammals and other species, puberty is the key transitional period when sexual maturity, and hence the capacity to reproduce, is achieved (Parent et al., 2003; Ojeda and Skinner, 2006; Ojeda et al., 2010; Plant, 2015) , along with the occurrence of important somatic (growth), behavioral and psychological changes. The endpoint of such maturational continuum, founded on previous key developmental events, including sexual differentiation, is the acquisition of the complete adult phenotype.
As a life-changing event in the vital course of any individual, the timing of puberty is under strong genetic determination (Gajdos et al., 2010) , but tightly controlled also by a myriad of endogenous and exogenous factors (Parent et al., 2003) . This is epitomized by the dramatic impact of conditions of metabolic stress, ranging from malnutrition to obesity, on the age of puberty in humans and other mammals (Castellano and Tena-Sempere, 2016a,b) . Similarly, other environmental signals (from climate cues to endocrine disruptors (EDs)) and endogenous conditions (from strenuous exercise to wasting chronic diseases) have a substantial impact on pubertal maturation (Parent et al., 2003 , thereby affecting proper somatic and reproductive maturation. Realization of such a dynamic interplay and of its pathophysiological implications has fueled very active research on the intimate mechanisms of puberty, its modifiers and the basis of its deviations, with the ultimate aim to better understand how puberty is controlled in health and disease.
Hormones and the brain work in concert to time puberty onset
While puberty is a multifaceted phenomenon, in this review we will focus our attention on the events leading to the attainment of reproductive capacity, as hallmark of pubertal maturation (Plant, 2015) , with particular emphasis on the central components of such maturational process. Reproduction is operated by the hypothalamic-pituitary-gonadal (HPG) axis, whose function is primarily driven by the dynamic interplay of three major groups of factors, originating from: (i) the hypothalamus, where a relatively scarce population of neurons produce the decapeptide, gonadotropin-releasing hormone (GnRH); (ii) the anterior pituitary, where both gonadotropins, LH and FSH, are synthesized; and (iii) the gonads, responsible of the production of gametes and the release of sex steroids and peptides (Tena-Sempere and Huhtaniemi, 2003) . These elements are connected by stimulatory feed-forward loops, resulting in gonadal maturation, steroid/peptide hormone secretion and complete gametogenesis (which is mandatory to attain reproductive competence). In addition, gonadal hormones feedback to the upper levels of the HPG axis to auto-regulate, via negative and (in females) also positive loops, the functioning of this neurohormonal system (Herbison, 2016) . Notably, the interaction between the different elements of the reproductive axis undergoes significant fluctuations during fetal and postnatal development (Tena-Sempere and Huhtaniemi, 2003) , including substantial changes during the pubertal transition.
Within the HPG axis, a major hierarchical element are GnRH neurons, which directly or indirectly receive regulatory inputs from a wide array of regulatory signals and pathways, involving numerous circulating hormones, neuropeptides and neurotransmitters (Fink, 2000) , and operate as final output for the brain control of reproduction (Herbison, 2016) . In fact, the onset of puberty is driven by the enhancement in the neurosecretory activity of GnRH neurons that translates into an increase of pulsatile LH secretion (see Fig. 1 ), one of the initial neuroendocrine manifestations of puberty onset (Lomniczi and Ojeda, 2016) . The immediate question is how GnRH neurons become activated at the time of puberty, and whether excitatory or (a decrease in) inhibitory events are the primus move in the onset of puberty. This intellectual discussion has extended for decades, since the formulation of the two major hypotheses to explain the basic mechanisms of pubertal activation, namely the gonadostat and the central-drive hypotheses, back in 1970s (Prevot, 2015) . While the former emphasized that initiation of puberty is caused by a decrease in the sensitivity of the GnRH system to the negative feedback of gonadal steroids, the latter stressed that primary changes at the central nervous Figure 1 Elements of the HPG axis and basic neuroendocrine mechanisms of puberty onset. A model, constructed mainly on the basis of preclinical (rodent) data, is presented of the major developmental events of the neuroendocrine centers governing the activation of female HPG axis at puberty. Key events in the transition from the infantile-juvenile period to the pubertal stage, depicted in the scheme, include: (a) changes in pulsatile GnRH secretion; (b) changes LH and FSH secretory profiles; and (c) major maturational events in the ovary. In addition, (d) the developmental changes of Kiss1 neuronal populations, with an increase in the number of these neurons and their projections to GnRH neurons, are represented by the magnification of these neurons in the scheme. Heightening of GnRH neurosecretion, as a result of these changes, and PM LH mini-surges precede the generation of the first pre-ovulatory surges of LH and FSH, which drive the first ovulation at puberty. Based on Prevot, 2015) , with substantial modifications. HPG, hypothalamic-pituitary-gonadal. system, and particularly on the networks controlling GnRH secretion, are responsible for setting puberty in motion. Experimental evidence in primates and rodents has refuted the occurrence of drastic changes in central negative feedback sensitivity before puberty (Prevot, 2015) . In contrast, it is now well accepted that both a decrease in inhibitory inputs and an increase in excitatory signals to GnRH neurons are required for pubertal activation (Lomniczi et al., 2015b ). Yet, the relative importance of inhibitory versus excitatory inputs, and how they actually interplay for the precise timing of puberty, still remains open.
The episodic secretion of GnRH, which is indispensable for pulsatile gonadotropin secretion and hence puberty onset, is the result of the interplay between the intrinsic oscillatory nature of GnRH neurons and, especially, a ample set of extrinsic excitatory and inhibitory afferents, which include not only trans-synaptic but also glial inputs, that integrate and have a dominant role in the so-called GnRH pulse generator (Ojeda and Skinner, 2006; Lomniczi and Ojeda, 2016) . While being crucial for puberty and fertility, the current view is that, within this system, GnRH neurons operate as transducers and major effectors for the regulatory actions of upper regulatory layers, which are essential for the dynamic integration of the numerous signals controlling the timing of puberty. In fact, system biology approaches, pioneered by Ojeda et al. in 2000s , have identified hierarchical hubs of genes and proteins that become activated or repressed at the time of puberty . This has supported the notion that, very possibly, puberty onset is not the result of a single trigger, but rather the consequence of the sequential activation and inactivation of excitatory and inhibitory networks, under the control of multi-layered and possibly redundant regulatory systems, whose nature is yet to be fully elucidated.
Timing of puberty: from physiology to translational medicine
That is all nice, but should clinicians and lay-public care? Indeed, they should. Apart from the exciting intellectual dimension of unraveling one of the most fascinating phenomena in human biology, we are apparently facing epidemiological changes in the age of puberty that are likely relevant for several reasons. First, these alterations, especially earlier puberty, which have been reported more frequently in girls but appear to occur also in boys (Aksglaede et al., 2009a; Herman-Giddens et al., 2012; De Leonibus et al., 2013) , might impact important developmental events, including somatic and psychological maturation, thus affecting adult height and increasing psychosocial problems. Moreover, perturbed pubertal timing is linked to numerous adverse health outcomes, including various gynecological, musculoskeletal, and neuro-cognitive disorders, as well as different cancers (Day et al., 2015a) , together with reduced life expectancy (Lakshman et al., 2009) . Likewise, earlier puberty is associated with an increased risk of cardio-metabolic disease, including hypertension and Type-2 diabetes, in both men and women (Day et al., 2015a) . However, association does not mean necessarily causation, and hence further translational research is needed to unveil the potential mechanisms and pathophysiological relevance of these phenomena, as prerequisite to define better strategies for the management of disorders of puberty and its eventual long-term consequences. Finally, since the tempo of puberty is very much dictated by the dynamic interplay between genes and environment throughout development , the trends for the rapid change in the age of puberty onset at the population level may be considered as sentinel for the suspected deterioration of the environmental influences on reproductive health (Aksglaede et al., 2009a,b) ; this is an issue that remains contentious and warrants further investigation. All these features have propelled the study of puberty and its deviations in recent years. In this review, we aim to provide a synoptic overview of recent progress in the field of neuroendocrine regulation of puberty, with special attention to advancements in our understanding of the neuropeptide and molecular mechanisms controlling pubertal timing, the basis for the metabolic control of puberty onset and the pathophysiological implications that the above physiological mechanisms may have.
Methods
On the basis of the above specific objectives, and departing from our own results and recent experimental and clinical data on these topics, a comprehensive MEDLINE search via PubMed website was conducted for articles published mostly from 2003 to 2017, using different combinations of keywords to cover such objectives. Data from cellular and animal models, as well as clinical studies, focusing on the pathophysiology of puberty in mammals were considered and cross-referenced with terms related to central neuroendocrine mechanisms, neuropeptides and neurotransmitters, metabolic control and energy homeostasis regulatory signals, as well as epigenetics and miRNA regulation. Special attention was paid to identify the species where the findings were reported, with emphasis on the systematic review of human data. Whenever relevant, discussion of our own work was included.
Neuropeptide pathways and the control of puberty: essential roles of kisspeptins
The neurochemical signals that orchestrate the developmental activation of GnRH neurosecretion, mandatory for the onset of puberty, have been actively analyzed in the last decades, and different neurotransmitters and peptides have been shown to participate in switching the balance between inhibitory and excitatory inputs to GnRH neurons. Among these, kisspeptins, the products of the Kiss1 gene, that operate via the cell surface receptor, Gpr54 (aka, Kiss1r), have emerged in recent years as master factor for the central control of puberty (Oakley et al., 2009; Navarro and Tena-Sempere, 2012; Pinilla et al., 2012) . While recognition of the essential function of kisspeptins in puberty onset should not overshadow the putative contribution of other neurotransmitters Pralong, 2010; Plant, 2015) , due to their paramount importance in reproductive control, kisspeptins should be singled out in the description of the neuropeptide pathways governing puberty. Admittedly, however, the actual role of kisspeptin signaling (e.g. whether it is the trigger, an essential amplifier or merely another regulatory layer of pubertal onset) is still matter of debate (Terasawa et al., 2013) .
Kisspeptins: master regulators of the reproductive brain and puberty
It is now universally admitted that kisspeptins are essential regulatory signals of GnRH secretion. GnRH neurons express Gpr54 and are activated by kisspeptins to release GnRH in different species Pinilla et al., 2012) . However, besides their direct effects, indirect actions of kisspeptins to modulate the GnRH system have been also documented Leon et al., 2016) . In mammals, two major populations of Kiss1 neurons have been found in the hypothalamus (Fig. 2) , located in the arcuate nucleus (ARC), or the equivalent infundibular region in humans, and the rostral hypothalamic area, mainly at the anteroventral periventricular nucleus (AVPV), as well-characterized in rodents (Smith et al., 2005; Garcia-Galiano et al., 2012b) . While these two populations are able to produce kisspeptins, the ARC and AVPV Kiss1 neurons are differentially regulated (e.g. by sex steroids) and seemingly play different roles in the control of key aspects of the function of the HPG axis, such as the negative (ARC neurons) and positive (rostral neurons) feedback control of gonadotropins . Moreover, while ARC Kiss1 neurons have been consistently detected in males and females of different species, a prominent population of AVPV Kiss1 neurons is detected only in females (mainly rodents).
The pubertal dimension of kisspeptins was disclosed by the initial publications reporting inactivating mutations of GPR54 in patients with hypogonadotropic hypogonadism (HH), associated with absence of puberty and infertility (de Roux et al., 2003; Seminara et al., 2003) .
These findings were later backed up by the demonstration of similar phenotypes in mice with genetic inactivation of Gpr54 or Kiss1 (Seminara et al., 2003; d'Anglemont de Tassigny et al., 2007) , and humans with inactivating mutations of the KISS1 gene (Topaloglu et al., 2012) . Those observations prompted specific analyses addressing the actual physiological roles of kisspeptin neurons in puberty onset. As a whole, those studies revealed a complex developmental program responsible for the activation of the Kiss1 neuronal system during the pubertal transition Pinilla et al., 2012; Tena-Sempere, 2013b ). This program seems to involve the following major components: (i) an increase in Kiss1 expression and peptide content in the hypothalamus during the pubertal transition; (ii) an increase in sensitivity to the secretory effects of kisspeptin on GnRH/LH release; (iii) an increase in Gpr54 signaling efficiency at GnRH neurons, coupled to some resistance to desensitization after prolonged kisspeptin stimulation (Roa et al., 2008); and (iv) an increase in the number of kisspeptin-positive neurons in the hypothalamus and of their projections to GnRH neurons (Clarkson and Herbison, 2006; Bentsen et al., 2010) . Altogether, these data jointly point to a heightening of hypothalamic kisspeptin Figure 2 Control of GnRH neurosecretion by Kiss1 neurons. A model, constructed mainly on the basis of rodent data, on the control of GnRH secretion by Kiss1 neurons in the hypothalamus is shown. Two major populations of Kiss1 neurons are depicted, located in the rostral (anteroventral periventricular nucleus, AVPV) and the mediobasal (arcuate nucleus, ARC) hypothalamus. Kisspeptins (Kp) released by these neurons are able to potently activate GnRH neurons to evoke GnRH release. The ARC Kiss1 neuronal population co-express, to a variable extent depending on the species, the TAC, neurokinin-B (NKB), and dynorphin (Dyn); hence, they are also referred as KNDy neurons. NKB and Dyn reciprocally regulate Kp neurosecretion (NKB: mainly stimulator; Dyn: inhibitor) acting on KNDy neurons. In addition, there is evidence for direct stimulatory effects of NKB on GnRH neurons. Kiss1 neurons are also under the regulation of other neuronal afferents; these are epitomized in the scheme by the input of POMC neurons in the ARC, which have been recently shown to modulate puberty by regulation of ARC Kiss1 neurons. In addition, other TAC, such as substance P (SP) and NKA, both encoded by the Tac1 gene, are expressed in independent neurons and seemingly stimulate AVPV Kiss1 and ARC KNDy neurons. In addition, evidence for a direct effect of SP on GnRH neurons has been presented. The main receptors mediating these actions are Gpr54, Kp receptor; NK1R, SP receptor; NK3R, NKB receptor; KOR, Dyn receptor. Based on Maguire et al., 2017) , with substantial modifications. TAC, tachykinin; POMC, pro-opiomelanocortin. expression and signaling during pubertal maturation. In fact, initial pharmacological data in various mammalian species already suggested that such an increase would suffice to evoke maximal secretory activity of the GnRH/ gonadotropin system and initiate puberty (Navarro et al., 2004a,b; Shahab et al., 2005; Plant et al., 2006) . Furthermore, pharmacological blockade of kisspeptin signaling delayed the onset of puberty in female rats, whereas ablation of Kiss1 neurons in the juvenile period prevented pubertal maturation in female mice Mayer and Boehm, 2011) .
Open questions on the pubertal roles of kisspeptins: trigger, amplifier or dispensable?
While the above findings demonstrate a prominent role of kisspeptin in pubertal progression, they do not solve fundamental questions regarding the actual nature of this function. For instance, is kisspeptin the long-sought trigger of puberty onset? Experimental evidence in rodents and primates argues against this possibility. Studies in female rodents have suggested that the pubertal expansion, and possibly activation, of rostral Kiss1 neurons critically depend on the actions of estrogen (Clarkson et al., 2009) . In fact, congenital ablation of estrogen receptor (ER)-α from Kiss1 neurons prevented completion of puberty, likely because of perturbed signaling from AVPV Kiss1 neurons (Mayer et al., 2010) . Alike, Kiss1 expression at the rostral hypothalamus was decreased in prepubertal female mice lacking brain ER-β, which also displayed delayed puberty (Naule et al., 2015) . Such dependence on estrogen input suggests that the initial stages of puberty, and hence the early increase of circulating sex steroids, must take place independently of the kisspeptin drive, at least in rodents. Therefore, the Kiss1 system might act as an indispensable amplifier, rather than the initial activator, of the secretory activity of GnRH neurons during puberty (Clarkson et al., 2010) . In fact, it has been hypothesized that kisspeptins, although being indispensable for puberty to proceed, do not have a major specific role in pubertal timing, but rather operate as conserved regulator of the GnRH pulse generator across the lifespan (Terasawa et al., 2013) . Hence, the absence of kisspeptin signaling would prevent puberty just because it would dampen the neurosecretory activity of GnRH neurons. This model envisions kisspeptins as an essential intermediate layer between upstream regulatory mechanisms (primarily involved in pubertal activation) and GnRH neurons, as the output effector for the brain control of the reproductive axis. This hypothesis, formulated mostly on the basis of primate data, neglects to some extent the precise regulatory mechanisms of Kiss1 expression and signaling that have been documented during the pubertal transition. However, it is possible that the actual roles of kisspeptins in defining the tempo of puberty may vary among species, as illustrated by the fact that the prepubertal restraint of GnRH pulse secretion is variably dependent on gonadal steroids in primates (largely independent) and rodents (largely dependent) (Terasawa et al., 2013) . Similarly, male and female puberty may involve different Kiss1-dependent mechanisms.
Another interesting issue that remains to be fully solved is that of the relative contribution of the different Kiss1 neuronal populations to the precise timing of puberty. This question is relevant given the clear differences in the molecular and neurotransmitter landscape, and possible origin, of the two main Kiss1 neuronal populations. This was initially addressed by neuro-anatomical analyzes in rodents aiming to characterize the development of ARC and AVPV Kiss1 neurons during the juvenile-to-pubertal transition. While those studies revealed a robust expansion in rostral Kiss1 neurons in female mice (Clarkson et al., 2009) , Kiss1 mRNA and peptide levels have been shown to rise also in the ARC of male rats along pubertal maturation . Further analyzes of the contribution of the two Kiss1 population included functional genomic and virogenetic approaches. Congenital ablation of ERα from Kiss1 neurons evoked earlier vaginal opening (VO; as external sign of the onset of puberty), due to precocious activation of ARC Kiss1 neurons, but prevented the first ovulation, due to suppression of AVPV Kiss1 neurons (Mayer et al., 2010) . On the other hand, partial knockdown of Kiss1 in the ARC versus AVPV by stereotaxic injections of adeno-associated viruses encoding kisspeptin antisense vectors delayed VO only after targeting AVPV Kiss1 neurons (Hu et al., 2015) . As potential caveat, though, this approach evoked only a moderate suppression of kisspeptin content (32% in ARC; 37% in AVPV), which might not be sufficient to fully disclose the pubertal roles of each Kiss1 population. Finally, in rodents, a third population of Kiss1-expressing neurons has been identified in the amygdala, whose function remains scarcely studied . Recent developmental analyzes have shown that Kiss1 expression in this area is virtually null in juvenile ages of male mice, whereas it rises significantly during the late pubertal period, at the time when increases in circulating sex steroids occur (Stephens et al., 2016) . Thus, this rise may not be the cause of puberty, but rather driven by the initial increase in sex steroids that takes place at early pubertal stages. Yet, the contribution of such activation of amygdala Kiss1 system to completion of puberty and/or consolidation of related phenomena (e.g. sex behavior) is yet to be elucidated. Interestingly, recent evidence suggests that this amygdala Kiss1 neuron population may be functional in humans, where kisspeptins have been shown to modulate limbic brain activity to integrate sexual and emotional behaviors with reproduction . However, the eventual role of this population in human puberty remains totally unexplored.
Despite the overwhelming evidence supporting a physiological role of kisspeptins in the control of puberty, it is noted that one study has documented that congenital ablation of Kiss1 neurons does not prevent the attainment of fertility in female mice (Mayer and Boehm, 2011) . This phenotype is in contrast with most of the studies showing that humans and mice with genetic inactivation of Kiss1 or Gpr54 genes lack pubertal maturation. One reconciling explanation could be that the former approach resulted in incomplete neuronal ablation and/or (very probably) developmental compensation. In fact, a genetic model of substantial (95%) congenital reduction in Kiss1 transcript abundance strongly suggests that redundancy (and potential compensation) in Kiss1 expression is a putative mechanism for safeguarding reproductive function against unfavorable conditions (Popa et al., 2013) . Such compensation was especially evident in males, whereas females with equivalent central Kiss1 suppression displayed profound alterations in ovulation and fertility.
Co-players of kisspeptins in the control of puberty: roles of neurokinin-B and melanocortins
Recognition of the fundamental roles of Kiss1 in the control of puberty and reproduction led to the active search for the major regulatory mechanisms and interactive partners of kisspeptins. On the latter, substantial advancements have been made recently, and are epitomized by the identification of neurokinin-B (NKB), other tachykinins (TAC) and dynorphin (Dyn), as major signals and co-regulators of Kiss1 neurons. These studies were grounded on initial pharmacological and expression analyzes, many of them preceding the discovery of kisspeptins, and were later revitalized by more recent genetic and functional data. While most of those studies have addressed the roles of such partners in adult reproductive function, some data on their role in puberty onset have been produced also, as reviewed in this section.
Pubertal roles of NKB, other TAC and KNDY neurons
Two major tantalizing, and almost contemporary findings connected NKB and kisspeptin signaling and directed considerable attention to their cooperation in the control of reproduction. In 2009, genetic studies demonstrated that humans with inactivating mutations of the genes encoding NKB (TAC3, whose ortholog is Tac2 in rodents) or its receptor, NK3R (TACR3), suffered lack of puberty onset and central hypogonadism (Topaloglu et al., 2009) , a phenotype reminiscent of that of patients with mutations of KISS1 or GPR54. In addition, initial studies in mice and sheep, later confirmed in other species (including humans), showed that in the ARC/infundibular region, Kiss1 neurons express NKB and NK3R. Since it was shown that these neurons also express Dynorphin (Dyn), the fortunate term 'KNDy' was coined to name this neuronal population (Lehman et al., 2010; Uenoyama et al., 2014) , which shows profuse inter-connections within the ARC. In contrast, Kiss1 neurons in the AVPV do not co-express NKB (Lehman et al., 2010) .
Admittedly, the level of co-expression of KNDy peptides in ARC Kiss1 neurons possibly varies as a function of sex and species; for instance, some neuroanatomical analyzes have shown a modest degree of overlap in the expression of kisspeptin, Dyn and NKB in the infundibular region of young men (Hrabovszky et al., 2012) . Yet, as much as 75% of Kiss1 neurons co-expressed NKB according to that study. Furthermore, molecular, anatomical and physiological data support a role of NKB as auto-regulatory signal for KNDy neurons, stimulating kisspeptin output to GnRH neurons (see Fig. 2 ). That NKB operates via kisspeptin signaling to modulate GnRH neurons is supported by a wealth of data, including the demonstration that desensitization of Gpr54 blocks the effect of senktide, an NKB agonist, on gonadotropin release in monkeys (Ramaswamy et al., 2011) , and the fact that ICV injection of senktide in rodents induces c-Fos in ARC Kiss1 neurons (Navarro et al., 2011) , which express NK3R (Navarro, 2013) and are excited by NKB (de Croft et al., 2013) . Moreover, the effect of senktide is absent in Gpr54 null mice (GarciaGaliano et al., 2012c) , but is preserved in mice engineered to maintain kisspeptin actions only in GnRH neurons . In keeping with a role of kisspeptin as distal signal for the stimulatory effects of NKB, kisspeptin infusion was able to restore LH pulsatility in humans with NKB signaling deficiencies (Young et al., 2013) , whereas blockade of NKB receptors in women, despite suppressing LH pulsatility, failed to alter kisspeptin-induced LH secretion, attesting that NKB signaling is upstream kisspeptin in the control of GnRH neurons also in humans (Skorupskaite et al., 2016) . Such positive effects of NKB on GnRH/gonadotropin secretion are not conserved in all experimental settings; yet, the above evidence strongly support a role of NKB signaling in stimulating kisspeptin output and hence GnRH secretion, at least in a range of physiological conditions. In addition, NKB signaling may act also as mediator for other reproductive-related manifestations, such menopausal hot flushes in women; which is an area where therapeutic options using NKB receptor antagonists have been proposed very recently .
Experimental studies, mostly in laboratory rodents, have suggested that NKB plays a relevant role in defining the tempo of puberty. Hence, in both female rats and mice, increased hypothalamic expression of Tac2 and Tacr3 has been shown to occur at early stages of prepubertal maturation (Gill et al., 2012; . In addition, NKB receptor agonism in vivo was able to increase LH secretion and advanced the timing of puberty Nakahara et al., 2013) , while NK3R blockade delayed puberty onset in female rats Li et al., 2014) . In good agreement, female mice engineered to lack NKB, namely Tac2-/-, displayed a profound delay in the timing of pubertal maturation . In turn, ablation of ERα from Tac2 cells, which eliminates the restraint imposed by the negative feedback of estradiol on NKB neurons, resulted in advanced puberty onset (Greenwald-Yarnell et al., 2016) . Interestingly, sex differences on the pubertal roles of NKB might exist, as Tac2-/-males did not show overt pubertal alterations , and LH responses to the NKB agonist, senktide, changed variably during postnatal maturation in male and female rats, with persistent responses after puberty being observed only in females . In any event, the dominant stimulatory effect of NKB on puberty onset is likely opposed by the inhibitory KNDy peptide, Dyn (see Fig. 2 ), as illustrated by the observation that administration of an antagonist of its receptor, the kappa-opioid receptor (KOR), resulted in advanced puberty onset and accelerated pulsatile LH release in female rats (Nakahara et al., 2013) .
NKB belongs to a large family of neuropeptides, termed TAC, which result, in rodents, from the differential processing of two genes, and include substance P (SP), neurokinin A (NKA) and other TAC-derived peptides, in addition to NKB (Steinhoff et al., 2014) . TACs exert their effects via different G protein-coupled receptors, including NK1R (encoded by Tacr1), the receptor for SP, and NK2R (encoded by Tacr2), the receptor for NKA. Very recently, considerable interest has been paid to elucidate the GnRH/gonadotropin stimulating actions of TACs other than NKB. In this context, strong evidence suggests that the SP/NK1R system may also participate in the central regulation of the HPG axis, likely via kisspeptin-dependent mechanisms (de Croft et al., 2013; Navarro et al., 2015) . In fact, classical studies in humans, rabbits and rats had shown that central administration of SP induced LH release (Arisawa et al., 1990; Coiro et al., 1992; Traczyk et al., 1992) , while more recently, electrophysiological studies have documented that Kiss1 neurons are activated by SP (de Croft et al., 2013) . In addition, SP immunoreactivity has been found in the ARC of rodents (Rance and Bruce, 1994) , as well as in Kiss1 and NKB neurons in the human infundibular nucleus (Hrabovszky et al., 2013) . In good agreement, a stimulatory role of SP on puberty onset has been documented in female mice, since: (i) expression of Tac1 and Tacr1 was maximal in the ARC before puberty; (ii) administration of a SP agonist increased LH levels and advanced puberty onset; and (iii) female Tac1-/-mice displayed delayed puberty and impaired fertility . Moreover, delayed puberty has been also reported in male Tac1-/-mice very recently (Maguire et al., 2017) , therefore pointing to a prominent role of SP in the control of puberty in both sexes, at least in rodents.
Other members of the TAC family may participate also in the control of the HPG axis. For instance, NKA was able to induce electrical responses in GnRH neurons (de Croft et al., 2013) , and blockade of all three TAC receptors lowered gonadectomy-induced LH secretion, whereas blockade of the NK3R receptor alone did not (Noritake et al., 2011) . Moreover, not only NKB and SP agonists, but also NKA evoked potent LH-releasing effects in wild-type mice, which were blunted in Gpr54 knock-out (KO) mice . Hence, NKA also appears to interplay with other TACs and kisspeptins in the control of the reproductive system. However, to our knowledge, the putative role of NKA in the control of pubertal timing remains virtually unexplored.
Pubertal roles of melanocortins and other central transmitters
In addition to TAC and other KNDy peptides, several neuropeptidergic systems likely cooperate with kisspeptins in the precise control of puberty. This is well illustrated by the function of melanocortins, especially α-melanocyte stimulating hormone (α-MSH), as the major product of neurons in the ARC expressing the pro-opiomelanocortin (POMC) gene (Garfield et al., 2009) . α-MSH acts via melanocortin receptors, MC3R and MC4R, to conduct a wide array of biological actions. Besides its fundamental role as a first-order element in the central control of body weight and energy homeostasis , α-MSH is likely involved in the control of the adult reproductive axis, as documented by the fact that POMC terminals synapse with GnRH neurons and POMC peptides modulate gonadotropin secretion. Yet, these gonadotropic effects appear to be variable: although α-MSH has been shown to predominantly activate GnRH neurons and LH secretion (Roa and Herbison, 2012) , inhibitory effects have been also reported (Elias and Purohit, 2012; Xu et al., 2012) . In this context, fragmentary evidence had been presented for potential interactions between POMC and Kiss1 neurons (Backholer et al., 2010; Fu and van den Pol, 2010) , which might help to explain, at least partially, the central stimulatory effects of α-MSH on the HPG axis.
Despite the above evidence, the pubertal roles of melanocortins had remained underexplored until very recently, when ManfrediLozano et al. reported that activation of central α-MSH signaling potently activated the reproductive axis in pubertal rats, mainly via stimulation of MC4R, whereas chronic inhibition of melanocortin receptors by central administration of a MC3/4R antagonist, delayed puberty onset . The pathway whereby α-MSH signaling influences puberty likely involves the modulation of kisspeptin output onto GnRH neurons. This is supported by the observation of direct connections between α-MSH fibers and Kiss1 neurons in ARC of pubertal female rats, in which chronic blockade of central MC3/4R signaling caused a reduction of Kiss1 mRNA expression . In addition, mice with congenital ablation of Gpr54 displayed blunted LH responses to an α-MSH agonist, while inducible, DREADD-mediated inhibition of ARC kiss1 neurons resulted also in reduced LH secretory responses to MC3/ 4R activation. Altogether, these findings document a novel α-MSH to Kisspeptin to GnRH neuronal signaling pathway with a prominent role in regulation of puberty onset. Notably, this circuit is likely to contribute to the modulation of puberty by metabolic signals, as described in detail later in this review.
While the above pre-clinical evidence is solid, it must be noted that the data supporting a putative role of POMC/melanocortin signaling in human puberty remains scarce. Case reports have documented mutations invalidating the POMC gene or the processing of POMC that result, among other endocrine defects, in hypogonadotropic hypogonadism (HH) and lack of puberty (O'Rahilly et al., 1995; Clement et al., 2008) . In turn, variants in the MC4R gene have been found in a limited set of girls with precocious puberty (Roldan Martin et al., 2004) . Of note, the possibility that such alterations of POMC/melanocortin signaling may impact pubertal timing indirectly, e.g. by perturbing other endocrine axes or by causing excess of adiposity, cannot be discarded and warrants further investigation.
While for sake of brevity in this section we have focused on NKB, other KNDy peptides and melanocortins (summarized also in Table I ), it is important to emphasize that other neurotransmitters are known to cooperate with kisspeptins (or act independently) to modulate pubertal timing. As an illustrative example, the gaseous transmitter, nitric oxide (NO), has been proposed to mediate at least some of kisspeptin actions, since neurons in the preoptic area (POA) expressing the NO synthesizing enzyme, nNOS, have been shown to express Gpr54 and to respond to kisspeptin in terms of nNOS phosphorylation (Hanchate et al., 2012) . Furthermore, nNOS deficient mice display central hypogonadism (Gyurko et al., 2002) , although it is milder than that seen in mutants of the Kiss1 system. Likewise, interplay between GABAergic and kisspeptin signaling has been suggested by pharmacologic and functional genomic studies; e.g. GABA-A receptor activation attenuates LH responses to kisspeptin (GarciaGaliano et al., 2012a; Martin et al., 2014) .
Roles of epigenetics in the central control of puberty
While attempts at the elucidation of the molecular basis of the sophisticated developmental program of puberty made initial emphasis on transcriptional changes occurring during the pubertal transition at discrete brain regions (Lomniczi et al., 2015b; Lomniczi and Ojeda, 2016) , such as the mediobasal hypothalamus (MBH), recent efforts have been directed towards the characterization of other, non-classical regulatory mechanisms of gene/protein expression, including prominently, epigenetics. Conceptually, epigenetic regulatory mechanisms are nicely suited for the regulation of complex biological phenomena, such as puberty, as they might participate in both long-term developmental modifications induced by geneenvironment interactions (e.g. in sex differentiation) as well as in rapid (even cyclic) changes of specific pathways. Yet, the basis for the putative epigenetic regulation of puberty onset has begun to be disclosed only very recently.
The multifaceted nature of epigenetic regulatory mechanisms
Epigenetics refers to the inheritable information that is not encoded by the mere nucleotide sequence of a given gene (Paulsen et al., 2008) , but rather by changes occurring upon the genome that profoundly influence gene/protein expression. Therefore, epigenetic changes can drive differences in the phenotype without changes in the genotype (Jaenisch and Bird, 2003) . Epigenetic modifications can either be spontaneous, or driven by internal or environmental factors, and may result in disease when deregulated (Benite-Ribeiro et al., 2016). Three major forms of epigenetic modulation have been identified: DNA methylation, post-translational modification of histones and noncoding (nc) RNAs (Lomniczi et al., 2015b) ; the latter include small ncRNAs, also termed microRNAs, whose contribution to the regulation of puberty will be addressed in more detail later in this review.
Epigenetic changes involving DNA methylation and histone modifications have been proven physiologically relevant in numerous biological processes (Paulsen et al., 2008; Sims et al., 2008; Van Emburgh and Robertson, 2008) . DNA methylation involves the addition of a methyl group to position 5 of cytosine residues (5mC), especially in CG enriched DNA sequences, termed CpG islands (Ziller et al., 2013) . In general, methylated CpG islands denote an inactive promoter with chromatin in a close state (heterochromatin), therefore resulting in blockade of gene expression. DNA methylation is mediated by DNA methyltransferases (DNMTs), which include DNMT1, DNMT2, and DNMT3a and DNMT3b (Singh et al., 2013) .
The counterpart of DNMTs is the family of Ten-eleven translocation (TET) enzymes, responsible for active DNA demethylation (Rasmussen and Helin, 2016) . Hence, the balance between DNMTs and TET activity is determinant for transcriptional activity. Methylation may also be linked to gene activation depending on the location of epigenetic marks.
Epigenetic changes on histones have been shown to involve a variety of potential post-translational modifications, including acetylation, methylation, phosphorylation, ubiquitination and sumoylation (Kouzarides, 2007) , mainly at the N-terminus tails. Histones (H) are key components of nucleosomes, the fundamental repeating unit of chromatic structure, which consist of 147-bp DNA wrapped around an octameric histone core comprising two copies each of H2A, H2B, H3 and H4. As such, histones not only provide the structural block to support DNA, but also contribute to ensure DNA packaging and thereby influence transcriptional activity.
Histone acetylation is carried out by histone acetyltranferases, while histone deacetylases are responsible for removal of acetyl groups. Histone acetylation is usually correlated with transcriptional activation, whereas deacetylation leads to gene silencing (Lomniczi et al., 2015b) . In the case of histone methylation, the impact on gene activity is not univocal. This process is mediated by histone methyltransferases, and may lead to activation or repression of gene transcription. H3 methylation of Lys 9 and 27 (H3K9me and H3K27me) is usually found in silenced genes, while tri-methylation of H3 at Lys 4 (H3K4me3) is a signal of open chromatin and therefore gene transcription. Details of other forms of histone modifications can be found elsewhere (Kouzarides, 2007 ). Yet, methylation/demethylation of DNA and histones, as well as histone acetylation are the prime mechanisms of epigenetic control of gene transcription (Lomniczi et al., 2015b) . In addition, recent data have pointed out the important role of two different complexes composed of chromatin proteins with mutually antagonistic activity, namely, the Polycomb group (PcG) and Thritorax group (TrxG), which are targeted by epigenetic changes (e.g. methylation of members of the PcG). Activation of PcG silencers is associated with gene repression, whereas TrxG is considered to function as transcriptional activator, by antagonizing PcG silencing (Lomniczi and Ojeda, 2016) . Some histone modifications, such as ubiquitination of H2A and H2B, have been shown to control also the activity of PcG and TrxG groups.
Epigenetic control of puberty: targeting GnRH and Kiss1/KNDy neurons
Realization of the important role of epigenetics in the central control of puberty has occurred only recently. However, previous fragmentary evidence had pointed out the relevance of epigenetic changes in key maturational events, such as brain sex differentiation, which precede and influence pubertal timing. Studies in rodents disclosed that estrogen-dependent brain sexual differentiation is modulated by epigenetic modifications during fetal and perinatal critical periods (McCarthy and Nugent, 2013) , as illustrated by the impact of early manipulation of histone acetylation/deacetylation on the sexual differentiation of the bed nucleus of stria terminalis and vasopressin fibers, as well as adult sexual behavior (Matsuda et al., 2011; Murray et al., 2011) . In addition, a sexually differentiated trait, such as the expression levels of ERα in the hypothalamic preoptic region (females show higher expression than males), was inversely correlated with the methylation status of ERα promoter (Kurian et al., 2010b) . Social (maternal grooming) and hormonal (estrogen exposure) interventions during early critical periods obliterated such sex differences, with females displaying a masculinized pattern of ERα promoter methylation and expression (Kurian et al., 2010b) . These findings, summarized in Table II , illustrate the lasting consequences of epigenetic changes on early maturational events preceding puberty.
Given their paramount importance in puberty and reproductive function, attention has been paid to elucidate the potential epigenetic mechanisms controlling the GnRH and Kiss1 systems. However, the number of studies remains low and not all of them have specifically targeted the pubertal transition. The first evidence for the epigenetic control of GnRH neurosecretion appeared in 2010 when, using cultures from non-human primates, Kurian et al. reported that the increase in GnRH expression that occurs along GnRH neuronal maturation coincides with demethylation of several CpG islands of the GnRH promoter (Kurian et al., 2010a) . Further support for such a regulatory mechanism has been presented recently in a mouse study showing that the expression of the enzyme tet2, a member of the TET family of DNA demethylases, increases with age in the preoptic (Semaan et al., 2012) A synopsis of the most relevant epigenetic regulatory mechanisms controlling the HPG axis and its activation at puberty is presented. Information regarding major effects, receptors and mechanisms involved is shown. In addition, indication is made of the species and sex where the supporting data have been obtained.
area of the developing mouse and that tet2 over-expression in a clonal GnRH neuronal cell line (GT1-7) enhances GnRH expression (Kurian et al., 2016) . However, the physiological relevance of such regulatory mechanism in the control of pubertal timing is questioned by the fact that congenital ablation of tet2 in GnRH neurons failed to cause overt alterations in the age of puberty in either sex, although it resulted in lower LH levels and later subfertility, which might suggest a more prominent role of this demethylation pathway in maintenance, rather than activation, of GnRH neuronal function (Kurian et al., 2016) . Studies on the epigenetic regulation of Kiss1 have targeted different developmental stages. In 2013, Ojeda et al. reported that changes in the methylation status at the MBH of various genes of the PcG occurs during the pubertal transition in the female rat (Lomniczi et al., 2013) . The PcG system is a crucial regulator of gene expression, with three major repressor complexes, namely, PRC1, PRC2 and PhoRC, which cooperate to cause gene silencing. Notably, the expression of Cbx7 (member of PRC1) and Eed (member of PRC2) decreased in the MBH at the time of puberty, and such declines were associated with increased promoter methylation. These studies disclosed also that Kiss1 is a downstream target of PcG repression: Cbx7 and Eed are co-expressed in ARC Kiss1 neurons, and EED protein binds to the Kiss1 promoter, but such association declines at the initiation of puberty, thus lifting a putative repression (Fig. 3) . This was further confirmed by molecular analyzes showing that eviction of EED from the Kiss1 promoter at the time of puberty coincided with the increase of two activator histone marks, H3K9,14ac and H3K4me3. Furthermore, in vivo over-expression of EED in the MBH of female rats resulted in 50% suppression of ARC Kiss1 expression, perturbed GnRH secretion and delayed puberty (Lomniczi et al., 2013) .
The studies of Ojeda et al. disclosed the molecular basis of a complex system of transcriptional repression, finely tuned by epigenetic mechanisms, that keeps puberty in check, preventing early activation of the HPG axis (Lomniczi et al., 2015b) . The conserved role of such mechanism of transcriptional repression has been recently confirmed by primate studies demonstrating that expression of members of the family of zinc finger (ZNF) genes is down regulated in the MBH of male and female monkeys at the juvenile-pubertal transition (Lomniczi et al., 2015a) . In particular, expression of two ZFN genes, GATAD1 and ZNF573, was decreased in peripubertal female monkeys, while their over-expression in rat hypothalamus delayed puberty onset. Interestingly, GATAD1 operates as repressor of human KISS1 and TAC3 genes, directly and by promoting demethylation of the activator Figure 3 Epigenetic mechanisms and the control of puberty. Some of the major mechanisms proposed to date for the epigenetic regulation of key puberty-regulating genes are depicted. In the upper panel, data from rodent studies on the interplay between PcG and TrxG regulatory factors at the Kiss1 promoter during the pubertal transition are shown. During pubertal maturation, eviction of members of the PcG, such as EED and CBX7, from the Kiss1 promoter allows a change in the chromatin landscape, with an increase in the abundance of two activator histone marks, H3K9,14ac and H3K4me3, and a decrease in the inhibitory mark, H3K27me3. These changes result in an increase in Kiss1 transcription, denoted in the scheme by recruitment of RNA Polymerase II (POL-II), which is key for puberty onset. In addition, results from non-human primate studies, illustrating the regulatory roles of zinc finger proteins (ZNF) on KISS1 and TAC3 promoters, are summarized. In detail, the ZNF protein, GATAD1, is able to repress KISS1 and TAC3 promoters directly, and via recruitment of the histone demethylase, KDM1A, which induces demethylation of the activator mark, H3K4me2. Eviction of the GATAD1/KDM1A complex during puberty permits the pubertal activation of KISS1 and TAC3 transcription. Based on data from (Lomniczi et al., 2015a; Lomniczi and Ojeda, 2016) , with substantial modifications. PcG, Polycomb group; TrxG, Trithorax group. mark, H3K4me2, due to its capacity to recruit the histone demethylase, KDM1A (Lomniczi et al., 2015a) . Hence, lowering of epigenetic repression of Kiss1 (and related genes), via suppression of PcG and ZNF members, appears to be a conserved mechanism for timing puberty in mammals. The translational relevance of such mechanism is supported by findings from genome-wide association studies (GWAS) showing that SNPs located near some ZNF genes are linked to an earlier age of menarche (Elks et al., 2010; Perry et al., 2014) . As counterbalance, it has been recently suggested that members of the TrxG family of transcriptional activators might oppose these repressive mechanisms (Lomniczi and Ojeda, 2016) ; see also Fig. 3 . Although this possibility needs to be investigated further, such a system would allow a proper balance between activator and inhibitory inputs during the pubertal transition.
Other epigenetic regulatory mechanisms of the HPG axis along the lifespan Epigenetic control of Kiss1 seems to occur also at other development periods; see Table II . Thus, pharmacological blockade of histone deacetylation during the early postnatal period moderately increased Kiss1 expression in the AVPV in both male and female mice at adulthood, although did not prevent the sex dimorphism (higher Kiss1 expression in females than males) at this nucleus (Semaan et al., 2012) . In addition, differences in the methylation status of several CpG sites at the Kiss1 promoter and Intron1 have been found between males and females, selectively in the AVPV. Notably, four CpG sites were hyper-methylated in females; this finding is somewhat counter-intuitive as Kiss1 expression is substantially higher in adult females. One tenable explanation is that methylation of Kiss1 promoter may prevent interaction with transcriptional repressors. Another report in the mouse has documented an increase in histone acetylation (but no changes in DNA methylation) in the Kiss1 promoter at the AVPV, as mechanism for estrogen-induced positive feedback, in which an increase in Kiss1 expression occurs. In contrast, estrogen evoked histone deacetylation in the ARC, coincident with suppressed Kiss1 expression (Tomikawa et al., 2012) . The epigenetic mechanism whereby estrogen stimulates AVPV Kiss1 expression involves also changes in chromatin looping and enhanced interaction between the Kiss1 promoter and an estrogen-responsive enhancer inter-genic region located downstream of the Kiss1 gene, occurring selectively at the AVPV (Tomikawa et al., 2012) . Whether similar mechanisms participate in heightening Kiss1 expression at the AVPV during prepubertal maturation remains unexplored.
MicroRNA pathways and the central control of puberty
In addition to DNA methylation and histone modifications, epigenetic regulation via ncRNAs has been shown to play a fundamental role in the regulation of wide array of cellular and body functions. Among them, small ncRNAs, termed microRNAs (miRNAs), have been by far the most studied family of non-coding RNAs. While evidence concerning the regulation of neuroendocrine and reproductive events in general by miRNAs remains scarce, promising, though as yet incomplete, evidence has recently suggested the involvement of miRNA regulatory pathways in the central control of puberty.
The fascinating biology of microRNAs
MiRNAs are small (~22 nucleotide in length) ncRNAs with capacity to regulate the expression/translation of myriad of gene targets (Bartel, 2004; Sayed and Abdellatif, 2011) . Nuclear expression of intragenic (excised from intron sequences of other host genes) or intergenic (transcribed from specific promoters by polymerase II) miRNAs results in the generation of long primary transcripts, named pri-miRNAs, with hairpin structure and two-nucleotide ledge, which are later processed by the nuclear enzyme, Drosha (RNase III), and its partner DGCR8 (DiGeorge syndrome chromosomal region 8), to produce~70-nt stem-loop shaped precursor miRNAs, named premiRNAs. After translocation to the cytoplasm by the nuclear transmembrane protein, exportin-5, pre-miRNAs undergo a second excision, mediated mainly by the RNAase III enzyme, Dicer. This results in the generation of RNA duplexes of double-chain and small size (19-25 nt per chain), which contain two antiparallel miRNAs, one in 5′ direction and another in 3′ direction. Mature miRNAs dissociate and one of the pair is incorporated into the RISC (RNA-induced silencing) complex, which is bound to that miRNA guide. The RISCmiRNA complex then binds at specific seed regions to recognition sequences in the target mRNAs, with complete or partial complementarity (Sayed and Abdellatif, 2011) . This interaction results in most cases in translation suppression or RNA degradation, therefore causing gene silencing. Recognition sequences for miRNA binding are usually located at the 3′-UTR of target genes. Yet, some miRNAs may operate upon recognition sites located in the coding or 5'-UTR regions of certain genes, therefore regulating transcription (Rennie et al., 2016) . In addition, despite their predominant suppressive actions, there are examples that specific miRNAs can enhance gene expression.
Interestingly, a single miRNA can simultaneously target recognition sites at different genes, which allows it to collectively operate upon multiple components of the same, related or distinct biological routes (Yu, 2008) . Bioinformatic predictions suggest that one miRNA may have up to 100 different gene targets. In turn, a single gene can be regulated by multiple miRNAs. Additionally, miRNA expression in different tissues is under the control of various regulatory signals, including endogenous factors and environmental cues (Prieto and Markert, 2011) . Such diversity, in terms of miRNAs, targets and modifiers, results in an exponential combination of regulatory mechanisms that confer considerable plasticity to the system, optimal for the control of complex biological phenomena, such as puberty.
While initial interest in the putative roles of miRNAs in mammals focused on their involvement in the control of key aspects of cell proliferation, cancer biology and stem cell regulation (Davalos and Esteller, 2010) , convincing evidence has documented in recent years a prominent role of miRNA regulatory pathways in multiple body systems, including hematopoiesis, neuronal development, glucose homeostasis, insulin sensitivity and peripheral metabolism (Zhang et al., 2007; Rivera and Bennett, 2010; Jordan et al., 2011; Zhu et al., 2011; Vienberg et al., 2017) . However, less progress had been made in the characterization the eventual physiological and pathophysiological relevance of miRNA regulation of different neuroendocrine functions, including the central control of the HPG axis. However, recent evidence, summarized in Table III , suggests the participation of miRNA pathways in the precise regulation of puberty onset. While for the sake of focus, we will concentrate in this section on central (hypothalamic) mechanisms, miRNAs have been shown to play prominent roles also in the control of gonadal maturation and function (Grossman and Shalgi, 2016) . Likewise, rodent data have pointed out that the members of the mir-200 family, mir-200b and mir-429, are indispensable at the pituitary level for ovulation and fertility (Hasuwa et al., 2013) , whereas very recently, mice engineered to lack mir-7a2 were reported to lack pubertal maturation and to be infertile, possible due to primary defects of gonadotropin secretion at the pituitary (Ahmed et al., 2017) ; see also Table III .
MicroRNA pathways and the control of puberty: data from GWAS and experimental studies
The first (indirect) evidence linking miRNA regulation and puberty was provided by various GWAS that identified an association between the age at menarche and variability at 6q21, in or near the Lin28B locus (Elks et al., 2010) . Lin28B, and the related Lin28A, are RNA-binding proteins whose major known function is to block the processing of miRNAs of the let-7 family (Fig. 4A ). This action is conducted both at the nucleus, by blocking pri-and pre-miRNA export, and the cytoplasm, where Lin28 protein can prevent interaction with Dicer (Heo et al., 2008; Viswanathan et al., 2008) . In addition, a dynamic auto-regulatory loop involving c-Myc has been described, as c-Myc transcriptionally activates both Lin28A and Lin28B expression while let-7a represses c-Myc expression (Sampson et al., 2007) . In turn, other miRNAs, such as mir-145, mir-132 and mir-9 participate in the modulation of this regulatory hub by repressing c-Myc or Lin28 expression (Sachdeva and Mo, 2010) . Notably, functional genomic studies supported the pubertal role suggested for Lin28 by GWAS, since transgenic mice over-expressing this RNA-binding protein displayed overtly delayed puberty (Zhu et al., 2010) . However, those studies did not pinpoint the mechanisms and major site of action for such a repressive role of Lin28 proteins on pubertal timing, neither did they address the eventual role of let-7 miRNAs in the central control of puberty. Intriguingly, let-7 miRNAs were initially cataloged as putative tumor suppressors (Esquela-Kerscher et al., 2008); tumor-suppressor genes have been proposed to participate in the transcriptional control of puberty, with a detectable increase in expression at the time of puberty (Roth et al., 2007) .
To evaluate the putative function of the Lin28/let-7 tandem (and related factors), our group conducted a series of expression analyses in hypothalamic samples from maturing male and female rodents, both during normal postnatal development and in conditions of perturbed puberty. These analyses provided indirect evidence for a role of this putative regulatory hub in the control of puberty, since: (i) robust expression of Lin28B and the related Lin28A mRNAs was detected in rat and mouse hypothalamus, with a marked decline from the neonatal to the pubertal period-a trend that was not detected in the cerebral cortex (see Fig. 4B ); (ii) expression of let-7a and let-7b miRNAs in rat hypothalamus increased during postnatal A synopsis is presented of miRNA pathways and related factors putatively involved in the control of puberty. Information regarding major targets and potential mechanisms is shown. In addition, indication is made of the species and sex where the supporting data have been obtained, as well as on the developmental period in which these miRNA pathways potentially operate. See Table V for a glossary of terms regarding the Effect. development, with an inverse relationship with Lin28B mRNA levels, which is in agreement with a reciprocal regulatory loop (see Fig. 4B ); and (iii) models of delayed/absent puberty, such as neonatal exposure to sex steroids, displayed perturbed Lin28/let-7 ratios, with persistently elevated Lin28B expression and lower let-7 levels at the expected time of puberty (Sangiao-Alvarellos et al., 2013). Moreover, congruent changes in c-Myc (decreased) and mir-132 and mir-145 (increased) expression were detected in the hypothalamus during postnatal maturation. These data suggest that activation of putative repressors (let-7 and related miRNAs, mir-132 and -145) of a repressive signal (conveyed by Lin28) would contribute to set puberty in motion, by a net reduction of the Lin28/let-7 ratio at central (hypothalamic) levels during pubertal maturation. A substantial component of the above changes in Lin28/let-7 appeared to occur much before the peripubertal period (i.e. the infantile-juvenile transition), suggesting its involvement in early maturational events. Admittedly, however, these data did not provide evidence for the direct interplay of the elements of this regulatory hub with key components of the central networks governing puberty (e.g. GnRH or Kiss1 neurons), nor did they exclude the possibility that changes in Lin28/let-7 expression at other levels of the HPG axis, as reported in the gonads during postnatal maturation by our team (Gaytan et al., 2013; Sangiao-Alvarellos et al., 2015) , might contribute also to the pubertal actions of Lin28.
MicroRNA pathways and the control of puberty: targeting GnRH neurons
More recently, Messina et al. have provided direct evidence for a role of the miRNA regulatory machinery, specifically at GnRH neurons, in the control of puberty. Initial observations in mice engineered to lack Dicer (and hence, miRNA biosynthesis) selectively in GnRH neurons disclosed the fundamental role of miRNA pathways in the maturational program leading to GnRH neuronal activation at puberty, as GnRH-Dicer null mice failed to complete pubertal maturation and showed profound hypogonadism of central origin (Messina et al., 2016) . Additional work permitted the identification of some of the putative components of the miRNA pathways controlling postnatal activation of GnRH neurons (see Fig. 5 ). Again, key changes in these networks seem to occur also much before puberty onset, coinciding with early maturational events, such as mini-puberty at the infantile period in the mouse, and might involve the increased expression of repressors of repressors of GnRH (Messina et al., 2016) . This is the case of mir-200/429 and mir-155, whose expression increase in GnRH neurons and can repress, respectively, ZEB1 and CEBPB, which in turn inhibit key components of the GnRH neurosecretory machinery. Thus, ZEB1 is a repressor of GnRH directly and indirectly (by inhibiting some of its transcriptional activators), while CEBPB is a NO-dependent repressor of GnRH, both directly and via ZEB1 Figure 4 Putative miRNA pathways involved in the control of puberty: the Lin28/let-7 system. In the left panel (A), a scheme of the putative regulatory hub involving Lin28/Lin28B, miRNAs of the let-7 family, and related miRNAs and other factors, is presented. The roles of the enzymes, Drosha and Dicer, in the maturational process of let-7 miRNAs are also depicted. In the right panel (B), the profiles of expression of Lin28B in the hypothalamus (Hypo) and cortex of male and female rats, at neonatal and pubertal ages, are shown. In addition, the reciprocal changes in the hypothalamic expression levels of Lin28B and let-7b between neonatal, infantile and pubertal ages in male and female rats are illustrated. Based on data from (Sangiao-Alvarellos et al., 2013), with substantial modifications.
induction. Hence, the coordinated increase in the expression levels of mir-200 and mir-155 in GnRH neurons during the infantile period would permit to lift the repressive control of GnRH expression, mandatory for pubertal progression. Notably, the putative role of miRNA regulatory mechanisms in the control of the pubertal activation of Kiss1 neurons has not been elucidated to date. Yet, our group has presented initial evidence demonstrating that conditional ablation of Dicer from Kiss1 neurons in mice does not prevent early activator events linked to puberty (e.g. VO or preputial separation) but results in absence of complete pubertal maturation, profound central hypogonadism and infertility (Roa et al., 2017b) .
Metabolic regulation of puberty: peripheral signals and central targets
As an energy-demanding function, dispensable at the individual level, the acquisition of reproductive capacity is gated by nutritional and metabolic cues, with the aim of fitting puberty onset, and subsequent fertility, to the state of body energy reserves. Conditions of persistent negative energy balance, such as malnutrition, strenuous exercise or anorexia, delay or prevent puberty (Castellano and Tena-Sempere, 2016a,b) . Conversely, excess of body energy stores, as seen in obesity, has been linked to precocious puberty onset. This connection between energy status and the timing of puberty, which is especially evident in females, but also detectable in males, is known to rely on the complex interplay between peripheral signals and regulatory pathways at different levels of the HPG axis (Elias, 2012; Castellano and Tena-Sempere, 2016a,b) . Among those interactions, a prominent role of central mechanisms, involving key hypothalamic nuclei (e.g. ARC), neuronal populations (e.g. Kiss1 neurons) and cellular energy sensors (e.g. mTOR), has been highlighted recently, mainly in rodents, as summarized below.
Puberty is metabolically gated: roles of leptin and other metabolic hormones
The tight connection between puberty onset and the magnitude of body energy stores became scientifically formulated only in the 1960s Figure 5 Putative miRNA pathways involved in the control of puberty: regulation of GnRH neurons. A scheme is presented of major regulatory miRNAs and related repressive factors involved in the integral control of key changes in GnRH neurosecretion during the infantile-juvenile to pubertal transition. During this transition, a switch in the expression of mir-155 and mir-200/429 drives the increase in GnRH neurosecretion, which is essential for later pubertal development. This is mechanistically conducted via the capacity of these miRNAs to repress some key inhibitors of GnRH transcription, such as Zeb1 and Cebpb (the latter suppresses also Gpr54, as depicted also in the scheme), thus lifting a brake on GnRH expression. Based on data from (Messina et al., 2016) , with substantial modifications. and 70s, with the postulation of the critical fat mass hypothesis, which established that a certain threshold of body fat stores (i.e. energy reserves) need to be achieved in order to progress through puberty and reach reproductive capacity (Frisch and Revelle, 1970; TenaSempere, 2015) . However, this hypothesis, which focused mainly on girls, failed to identify the actual signals and regulatory centers responsible for this phenomenon. Despite some progress in the field, a major breakthrough in the characterization of the metabolic gating of puberty occurred only in 1994, when the adipocyte-derived hormone, leptin, was identified as key signal of energy abundance, with two major biological actions: to suppress food intake and to increase energy expenditure (Farooqi and O'Rahilly, 2014) . Leptin was found to circulate in the bloodstream in proportion to the magnitude of the adipose tissue, thereby acting as signal to the different body systems, including the reproductive axis, of the actual state of energy reserves. Accordingly, humans and laboratory animals bearing inactivating mutations of the genes encoding leptin or its receptor display severe pubertal disorders (Chou and Mantzoros, 2014; Farooqi and O'Rahilly, 2014) ; see also Table IV. Initial pharmacological studies in female rodents suggested that leptin may act as trigger of puberty; a finding that resounded with the observation that serum leptin levels are inversely related to the age of menarche in girls (Matkovic et al., 1997) . However, later evidence documented that, rather than a trigger, leptin operates as permissive factor for puberty to proceed; namely, threshold leptin levels are needed (but not sufficient per se) for attainment of puberty (TenaSempere, 2015; Castellano and Tena-Sempere, 2016a,b) . This permissive role was unambiguously documented by studies showing that leptin replacement in rodents and humans suffering leptin deficiency could revert the state of pubertal arrest but did not dramatically advance pubertal maturation (Farooqi et al., 1999) . In case of males, the putative permissive role of leptin in pubertal progression remained more contentious. Thus, while some studies showed that in boys puberty onset is preceded by a rise in leptin levels, which tend to return to baseline levels thereafter, others studies conducted in male monkeys and humans concluded that such as peak in circulating leptin is not needed for pubertal progression (Mantzoros et al., 1997; Plant and Durrant, 1997) . In any event, leptin deficiency is known to cause reproductive impairment in male rodents, while in men, decreased leptin levels have been shown to play a relevant role in metabolic and reproductive adaptations to short-term fasting (Chan et al., 2003) . Moreover, exogenous leptin administration to men sufficed to revert the reproductive/neuroendocrine phenotype caused by short-term starvation. All in all, the available evidence indicates that a minimal amount of leptin is needed to acquire (and maintain) reproductive function also in males.
Other metabolic hormones cooperate with leptin in the control of puberty (see Table IV ). These likely include the gut hormone, ghrelin, and the pancreatic hormone, insulin (Pralong, 2010; Tena-Sempere, 2013a,b) . Ghrelin is produced mainly by the stomach, in two major forms, acyl-ghrelin and unacyl-ghrelin (UAG). The former, referred hereafter as ghrelin, is considered the fully active form of the hormone, as it has the capacity to bind the canonical receptor, the growth hormone secretagogue receptor 1a (GHS-R1a), after incorporation of a medium-chain fatty acid by the enzyme ghrelin O-acyl transferase (GOAT) (Gutierrez et al., 2008; Yang et al., 2008) . In contrast, UAG was initially regarded as an inert product; yet, accumulating evidence suggests biological actions for this variant, whose receptor has not been clarified yet (Muller et al., 2015) . Ghrelin has been considered as a functional antagonist of leptin: it operates as orexigenic signal, whose levels increase in conditions of energy deficit (Zigman and Elmquist, 2003) . In good agreement, data gleaned over the last decade have strongly suggested an inhibitory role of ghrelin in the control of puberty and the HPG axis.
Admittedly, most of the studies on the reproductive effects of ghrelin have been conducted in adulthood, with limited attention being paid to its putative actions on puberty. Nonetheless, compelling evidence has pointed out an inhibitory role of ghrelin in the control 
Modulator/ Permissive (Clarkson et al., 2009; Mayer et al., 2010) 17β-Estradiol ( A synopsis is provided of some of the most relevant peripheral signals that participate in the metabolic control of puberty. For comparative purposes, the effects of estradiol (E2) are also summarized. Information regarding major effects, receptors and mechanisms involved is shown. In addition, indication is made of the species and sex where the supporting data have been obtained. See Table V for a glossary of terms regarding the Effect.
of puberty (Tena-Sempere, 2013a,b) , as illustrated by studies of chronic administration of different doses of ghrelin to rodents followed by monitoring of hormonal and phenotypic indices of puberty (Fernandez-Fernandez et al., 2005; Tena-Sempere, 2013a, b) . Those studies disclosed that, opposite to what has been reported for the pubertal effects of leptin, female rats appear to be less sensitive than males to the inhibitory actions of ghrelin on pubertal maturation ; a phenomenon whose physiological relevance is yet to be clarified. Of note, a recent study has documented that conditions of early subnutrition linked to delayed puberty are associated with increased hypothalamic expression of ghrelin at the time of puberty in female rats (Cui et al., 2014) . While indirect, this evidence is in line with a putative inhibitory action of ghrelin in the metabolic control of puberty, also in female rodents. Whether ghrelin plays a similar role in humans is yet to be fully elucidated. Yet, circulating ghrelin levels have been reported to decline progressively in boys and girls during the pubertal transition (Whatmore et al., 2003; Soriano-Guillen et al., 2004) , while ghrelin infusion has been shown to cause inhibition of spontaneous LH secretion in young men (Lanfranco et al., 2008) . Regarding insulin, data from human and functional genomic (mouse) studies have documented a predominant stimulatory/permissive role in the control of the gonadotropic axis, but as in the case of ghrelin, most of the available studies have focused on adult reproductive function, where the impact of insulin resistance and actions on the HPG axis have been extensively explored, e.g. in the context of the polycystic ovary syndrome (Vazquez et al., 2015) . In any event, in mice, congenital ablation of insulin receptors (IRs) in neurons results in profound hypogonadism of central origin (Bruning et al., 2000) , while suppression of circulating insulin levels is often associated with inhibition of gonadotropin secretion and reproductive perturbations both in experimental and clinical studies (Codner et al., 2012) . In fact, women with Type-1 diabetes have been reported to display delayed puberty. While the above data suggest a primary site of action of insulin at central (brain) levels, it is possible that part of the stimulatory/permissive effects of insulin on the HPG axis may stem from its capacity to increase leptin secretion.
Mechanisms and pathways for the metabolic control of puberty: leptin-mediated actions
The above observations raise the question on the primary sites and mechanism of action of these signals to convey metabolic information to the centers governing puberty onset. Admittedly, while we will focus in this section on brain (neuroendocrine) mechanisms, direct effects of the above metabolic signals on the gonads have been well documented (Codner et al., 2012; Tena-Sempere, 2013a,b) , and these can contribute to their impact on pubertal maturation. In any event, solid evidence suggests that a major integrator role is played by the hypothalamus, which bears neuronal populations able to 'sense' the metabolic milieu, by detecting hormonal, metabolic and nutritional cues, and to transmit this information to GnRH neurons, which operate as output pathway for the control of downstream elements of the gonadal axis. GnRH neurons themselves appear to be devoid of the major receptors for key metabolic hormones, such as leptin and insulin (Quennell et al., 2009; Evans et al., 2014) , and thus must rely on the transmission from upstream afferents, sensitive to metabolic cues.
In the search for such afferents, considerable attention has been devoted recently to elucidate the roles of Kiss1 neurons in the metabolic control of puberty. Initial findings conclusively demonstrated that hypothalamic Kiss1 neurons are sensitive to conditions of metabolic distress, so that states of negative energy balance cause a suppression of Kiss1 expression and kisspeptin content . Moreover, conditions of energy excess and obesity have also a discernible, albeit dual impact on the hypothalamic Kiss1 system: early-onset overfeeding linked to precocious puberty has been shown to increase hypothalamic Kiss1 expression in pubertal female rats , whereas persistent overweight in adulthood, commonly associated with variable degrees of hypogonadotropic hypogonadism, caused a suppression in hypothalamic Kiss1 expression and kisspeptin content in rats and mice (Quennell et al., 2011; SanchezGarrido et al., 2014) . Notably, NKB may cooperate with kisspeptins in signaling metabolic information to reproductive centers during the pubertal transition, since expression of the gene encoding its receptor, Tacr3, and to a lesser extent the ligand, Tac2, was suppressed in the ARC of pubertal female rats subjected to acute fasting . On the other hand, early post-weaning feeding with high-fat diet (HFD), which results in advanced VO, was linked also to increased expression not only of Kiss1 but also of Tac2 in the ARC . As evidence for the functional relevance of such changes in timing puberty onset, chronic central administration of either kisspeptin-10 or senktide (agonist of NKB) to immature females rats subjected to moderate subnutrition, which display delay puberty, was sufficient to rescue VO in 65 and 50% of animals, respectively, despite persistently suppressed body weight (Navarro et al., 2012) . 
Activator
Signal that evokes or elicits a specific neuroendocrine event; synonymous: inductor. Example: Kisspeptins activate GnRH neurosecretion by acting directly on GnRH neurons Amplifier Signal that, not being the trigger of a specific neuroendocrine event per se, can substantially magnify such phenomenon. Example: Kisspeptins seemingly operate as amplifier of the neuroendocrine (GnRH) activation that takes place during puberty Gatekeeper Factor that is indispensable for a specific neuroendocrine event to occur. Example: Kisspeptins are gatekeepers of puberty onset in humans and other mammals Permissive Factor that, not being an activator or amplifier, is mandatory for the manifestation of a specific neuroendocrine event. Example: Leptin is a permissive factor for puberty to proceed; i.e. minimum levels of leptin are required for puberty onset to occur Redundancy Phenomenon whereby different factors operate in the control of a specific neuroendocrine function inducing similar responses, so that one factor could compensate the lack of the other. Example: The hypothalamic control of energy balance is conducted by a redundant network of orexigenic and anorexigenic factors
Considering the fundamental role of leptin in the indirect control of GnRH neurons, the hypothesis that it acts directly on Kiss1 neurons to metabolically modulate GnRH secretion and thereby puberty onset was formulated. A wealth of experimental data was initially gathered supporting such a regulatory role. It was shown that leptin deficiency was associated with decreased hypothalamic Kiss1 mRNA expression, especially in the ARC (Castellano et al., 2006; Smith et al., 2006; Backholer et al., 2010) , and lowering of kisspeptin immunoreactivity in the AVPV (Quennell et al., 2011) . Conversely, leptin administration in animal models of leptin deficiency augmented hypothalamic Kiss1 expression; alike, leptin enhanced Kiss1 mRNA levels in neuronal cell lines (Castellano et al., 2006; Smith et al., 2006; Backholer et al., 2010; Sanchez-Garrido and Tena-Sempere, 2013; De Bond and Smith, 2014; Roa and Tena-Sempere, 2014) . In good agreement, initial reports documented the expression of leptin receptor (LepR) mRNA in ARC Kiss1 neurons in mice and sheep (Smith et al., 2006; Backholer et al., 2010) . In addition, studies in guinea pigs showed that leptin can depolarize ARC Kiss1 neurons via activation of transient receptor potential cation channels (Qiu et al., 2011) , while leptin depolarized~10% of ARC Kiss1 neurons in mice (Cravo et al., 2013) . The above evidence jointly suggested a tenable pathway for the metabolic regulation of GnRH neurons via direct actions of leptin in Kiss1 neurons.
However, despite the capacity of leptin to modulate Kiss1 neurons, expression and functional studies, including a model with conditional cell-specific ablation of LepR, have raised doubts on the possibility that leptin directly regulate Kiss1 neurons. Thus, female mice with targeted disruption of LepR in Kiss1 neurons failed to display overt alterations in the timing of puberty and were fertile (Donato et al., 2011) . While the possibility of incomplete LepR ablation and/or developmental compensation in this murine model exists, additional immunohistochemical studies in various molecular mouse models and sheep revealed that only a modest fraction of ARC Kiss1 neurons co-express functional LepR (Louis et al., 2011) . Depending on the study, the percentage of ARC Kiss1 neurons expressing LepR may range between 6 and 15% (Cravo et al., 2013) . Altogether, these data would suggest a predominantly indirect mode of action of leptin on Kiss1 neurons, as supported also by the identification of LepR-expressing neurons of undefined phenotype in the close proximity of ARC and AVPV Kiss1 neurons (Louis et al., 2011) . In this context, one study has suggested that expression of LepR in Kiss1 neurons may appear only during or after pubertal maturation (Cravo et al., 2013) , further suggesting the existence of additional indirect pathways for transmitting leptin actions to Kiss1 (and GnRH) neurons.
The identity of such intermediary neurons has been the subject of active investigation. On one hand, direct actions of leptin on glutamatergic neurons from the ventral pre-mammillary nucleus (PMV), a hypothalamic area essential for normal puberty onset, play an important role in the permissive control on puberty onset (Donato et al., 2009 (Donato et al., , 2011 Ratra and Elias, 2014) . Interestingly, bilateral lesions of the PMV impaired the physiological pattern of hypothalamic Kiss1 (and GnRH) expression, suggesting that Kiss1 neurons may transmit some of the leptin-PMV effects to GnRH neurons (Donato et al., 2013) . It must be noted, however, that only a subset of PMV neurons expresses LepR; thus, the impact of lesions of the PMV on puberty onset may derive, at least partially, from leptin-independent pathways.
Other intermediary circuits for transmitting leptin actions to Kiss1 neurons may involve POMC, cocaine-and amphetamine-regulated transcript (CART), Agouti-related peptide (AgRP), GABA and NOproducing neurons. Thus, recent evidence from our group has documented the indispensable role of α-MSH signaling for conveying the permissive effects of leptin on puberty onset, likely via a leptinmelanocortin-kisspeptin pathway . Part of this transmission might be mediated also via CART, co-expressed in POMC neurons, which is stimulated by leptin and can depolarize Kiss1 neurons (True et al., 2013) . On the other hand, while leptin has been shown to suppress AgRP neurons, ablation of AgRP neurons in leptin deficient (ob/ob) or LepR deficient (db/db) mice restored fertility and the timing of puberty (Wu et al., 2012) . While compelling evidence suggests that activation of Kiss1 neurons hyperpolarize AgRP neurons (Nestor et al., 2016) , the existence of a reciprocal AgRP to Kiss1 pathway had remained elusive until very recently, when an elegant combination of ablation and optogenetic approaches has documented that activation of ARC AgRP neurons results in inhibition of Kiss1 neurons in the ARC and AVPV (Padilla et al., 2017) . In addition, NOS neurons in the POA have been recently described as a novel site for the integration of leptin signaling and the metabolic control of puberty; NO actions seem mandatory for the permissive effects of leptin and interplay with kisspeptin signaling in the hypothalamic preoptic area (Hanchate et al., 2012; Bellefontaine et al., 2014) . Finally, ablation of LepR from GABA and glutamatergic neurons has recently highlighted a very relevant role of leptin actions in GABAergic neurons in transmitting its permissive actions on puberty onset (Zuure et al., 2013; Martin et al., 2014) ; mice lacking functional LepR in GABA neurons displayed delayed or absent VO and infertility, likely due to suppressed Kiss1 expression in the ARC (Martin et al., 2014) . The precise phenotype of such GABA neurons is yet to be fully elucidated, but may include POMC neurons of the leptin-melanocortin-kisspeptin pathway described above (ManfrediLozano et al., 2016) .
Putative central pathways for the control of puberty by other metabolic hormones
The central mechanisms whereby ghrelin and insulin operate onto the reproductive brain centers have not been so well defined. While expression of the canonical ghrelin receptor, GHS-R1a, is found in different brain areas, including prominently the hypothalamus (Guan et al., 1997) , no evidence for co-expression of GHS-R in GnRH neurons has been found . In fact, accumulating evidence suggests an indirect mode of action of ghrelin on GnRH neurons, which may involve different intermediary neuropeptides, such as neuropeptide Y (NPY) (Lebrethon et al., 2007) and corticotropinreleasing hormone (Vulliemoz et al., 2008) . In addition, a repressive interaction between ghrelin and Kiss1 neurons, which may contribute to the inhibitory action of ghrelin on puberty and reproduction, has been recently suggested. Thus, central administration of ghrelin suppresses not only pulsatile LH secretion but also hypothalamic Kiss1 expression, specifically in the rostral area (Forbes et al., 2009) . A more recent study documented that ghrelin receptor is expressed in a fraction of ARC Kiss1 neurons, while ghrelin induced electrical responses in Kiss1 neurons; notably, these were depolarization (i.e. presumably activational) responses and were augmented by estrogen (Frazao et al., 2014) . The physiological relevance of such phenomenon in terms of pubertal timing and its regulation by metabolic cues is yet to be defined. Likewise, the possibility of indirect actions of ghrelin in the control of Kiss1 neurons cannot be discarded, as an independent study using the GHSR-eGFP mouse failed to detect substantial co-expression of the ghrelin receptor in rostral Kiss1 neurons .
Regarding insulin actions, solid evidence demonstrated that while neuronal IRs are mandatory for normal puberty, this can proceed after conditional ablation of IR in GnRH neurons (Evans et al., 2014) , suggesting again an indirect mode of action. In this context, conflicting results have been presented for a putative insulin-kisspeptin interplay. On one hand, in conditions of insulin deficiency and decreased hypothalamic Kiss1 expression, central insulin administration failed to restore Kiss1 levels (Castellano et al., 2006) . In addition, conditional ablation of IR from Kiss1 neurons was compatible with pubertal maturation and fertility (Evans et al., 2014) . However, recent evidence has documented that pure insulin preparations can induce depolarization responses in Kiss1 neurons (Qiu et al., 2014) , and that combined ablation of LepR and IR from Kiss1 neurons, while being compatible with fertility, caused perturbations in the timing of puberty (Qiu et al., 2015) .
Central energy sensors and the metabolic control of puberty
Interest has been paid also to elucidate the putative role of cellular energy sensors acting at certain neuronal populations in mediating the metabolic control of puberty and the HPG axis, by integrating nutritional cues/energy status and the function of key elements of the reproductive brain, such as kisspeptin signaling. This is well illustrated by studies on the potential pubertal roles of mTOR (mammalian target of Rapamycin), a ubiquitous serine/threonine kinase that participates in the control of key cellular functions, including cell proliferation, growth and metabolism by sensing changes in energy status . In situations of energy/nutrient excess, mTOR is activated to switch on anabolic pathways. In addition to its role at the cellular level, hypothalamic mTOR signaling directly participate in the whole-body regulation of energy homeostasis, by integrating nutrient availability (mainly, amino acids) and hormonal milieu (e.g. leptin activates mTOR in the ARC). In this context, studies from our group strongly suggest that brain mTOR signaling is also implicated in the metabolic control of puberty acting, at least partially, as a transducer of the permissive effects of leptin. Thus, blockade of central mTOR by rapamycin inhibited the onset of puberty, as evidenced by delayed VO, lower LH and estradiol levels and decreased ovarian and uterus weight, and prevented the permissive effects of leptin on pubertal timing in a model of chronic subnutrition . Inactivation of mTOR significantly suppressed Kiss1 expression, mainly at the ARC, suggesting a leptin-mTOR-kisspeptin pathway for the metabolic control of puberty. Admittedly, it totally is plausible that mTOR modulation of Kiss1 expression may occur indirectly, via intermediary afferents of unknown phenotype, as fragmentarily suggested recently (Quennell et al., 2011) .
Another energy sensor that might cooperate with mTOR in this function is the AMP-activated protein kinase, AMPK, which, contrary to mTOR, becomes activated in conditions of energy deficiency, signaled by increased AMP/ATP ratios. Accordingly, leptin inhibits, while ghrelin activates phosphorylation of AMPK (Lopez et al., 2016) .
To the best of our knowledge, no study addressing the putative roles of hypothalamic AMPK in the metabolic control of puberty has been produced to date. Yet, fragmentary evidence suggests that, in keeping with its role as sensor of energy deficit, AMPK may transmit a negative valence to the elements of the (adult) reproductive brain. Thus, in vitro studies using the immortalized GnRH cell line, GT1-7, documented that pharmacological activation of AMPK was capable of suppressing Kiss1 expression (Wen et al., 2012) ; it must be noted, however, that GnRH neurons do not physiologically express Kiss1. On the other hand, in vivo experiments demonstrated that administration of agents known to activate AMPK to adult rodents resulted in perturbation of ovarian cyclicity and suppression of Kiss1/kisspeptin expression in the hypothalamus (Coyral-Castel et al., 2008; Wen et al., 2012) . In this context, our group has preliminarily reported very recently that central AMPK signaling plays a repressive role in the metabolic control of puberty, which is likely mediated by a suppression of ARC Kiss1 expression, a possibility further supported by functional genomic studies involving the ablation of α1-AMPK subunit in Kiss1 neurons (Roa et al., 2017a) . Admittedly, the modulatory actions of AMPK on the reproductive brain may occur at other sites, including GnRH neurons themselves and ependymocytes of the lower brainstem, where activation of AMPK may contribute to suppression of GnRH/LH secretion in conditions of negative energy balance (Roland and Moenter, 2011; Minabe et al., 2015) . To the best of our knowledge, however, the potential contribution of such sites of action in the metabolic control of puberty by AMPK has not been explored to date.
Novel mechanisms for the control of puberty: pathophysiological implications Advancement of our knowledge on the neuroendocrine systems controlling puberty has not only disclosed novel central pathways involved in the regulation of pubertal maturation, many of which had remained ignored until very recently, but has also illuminated new pathophysiological mechanisms underlying pubertal alterations. Analysis of these mechanisms has gained momentum with the recognition of the increasing incidence of pubertal disorders and the potential worrying implications of such disorders for health-span later in life (see the Introduction section).
Genetic basis of pubertal disorders: focus on neuropeptide and other regulatory pathways
Analysis of the genetic basis of puberty in population studies and monogenic forms of congenital HH has substantially advanced our understating of the genetic set-up responsible for normal pubertal progression and some of its deviations (Perry et al., 2014; Boehm et al., 2015) . A significant fraction of the age of puberty appears to be genetically determined. This is supported by observations from twin studies that estimate that roughly 60% of variation in the age of menarche is defined by genetic factors (Sorensen et al., 2013) , and more recent findings showing that both maternal and paternal pubertal age are strong determinants of the age of puberty in girls and boys (Wohlfahrt-Veje et al., 2016). However, despite such evidence for strong genetic determination, the information about specific gene determinants of pubertal age emerging from genetic studies remains scarce. GWAS have identified a number of loci whose variation causes (in general modest) variations in pubertal timing; the most prominent one being LIN28B, discussed detail in Section MicroRNA pathways and the central control of puberty. In addition, SNPs at or around genes known to influence body weight (e.g. FTO) or energy homeostasis (e.g. the receptor of the orexigenic factor MCH, or the transcription factors BSX and CRTC1) have been shown to associate with modest variations in the age of puberty (Elks et al., 2010; Day et al., 2015b) , illustrating further the tight association between body metabolic status and puberty onset. While many GWAS findings did not directly translate into evident regulatory pathways for the control of puberty, some of the identified genes are likely posed with clear mechanistic implications. This is the case not only of LIN28B, as a putative modulator of miRNA maturation, but also of CRTC1, whose genetic inactivation has been shown to cause puberty arrest due to impaired Kiss1 expression in genetic mouse models (Altarejos et al., 2008) . In any event, although GWAS have identified over a hundred loci as potential determinants of the age of puberty of in humans, altogether these seem to explain only a minute fraction (<5%) of pubertal variability (Elks et al., 2010; Wohlfahrt-Veje et al., 2016) . Interesting, the degree of hereditability seems to differ between sexes and markers of pubertal maturation; e.g. the age of breast development is less influenced by parental pubertal age than the age of menarche (Wohlfahrt-Veje et al., 2016) , indirectly suggesting the variable influence of environmental cues on these parameters.
On the other hand, analysis of the genetic causes of extreme variations of pubertal timing has been also instrumental in identifying novel regulatory pathways, with potential implications in the generation of pubertal disorders. This is well illustrated by recent advances in the identification of the basis of monogenic forms of congenital HH; a disease state characterized by lack of pubertal maturation and infertility. Indeed, in the clinical setting, consistent discrimination between constitutional pubertal delay versus idiopathic HH remains challenging (Trotman, 2016) , possibly reflecting a continuum of genetic defects and clinical manifestations that, to some extent, are shared between these two conditions. Mutations in more than 20 different genes have been causally linked to HH to date, some of which (e.g. those in GnRH, GnRH receptor, KISS1, GPR54, TAC3, TACR3, Leptin and LepR genes), although globally rare, have been essential to surface fundamental neuroendocrine pathways in the control of puberty in humans (Boehm et al., 2015) .
Interestingly, while mutations in numerous genes have been associated with delayed or absent puberty of central origin, only one causal gene for central forms of precocious puberty has been described so far: MKRN3, a maternally imprinted gene encoding the makorin RING-finger protein 3 (Abreu et al., 2013) . A number of heterozygous mutations in the MKRN3 gene have been reported to date in central precocious puberty, especially the familial forms, thus confirming the robustness of initial findings and the master role of MKRN3 in the activation of HPG axis at puberty (Bessa et al., 2016; Shin, 2016) . Regarding its mechanism of action, MKRN3 has been suggested to operate as repressor of central mechanisms responsible for pubertal awakening, thereby explaining the advancement of pubertal age linked to inactivating mutations. This mechanism is in line with the observed decline in the hypothalamic levels of expression of Mkrn3 gene in rodents during postnatal/pubertal maturation (Abreu et al., 2013) . However, whether (and if so, how) this decline lifts a restrain on the expression of genes encoding pubertyactivating factors, such as kisspeptins and NKB, is yet to be fully elucidated. Intriguingly, besides potential central actions, the circulating levels of MKRN3 have been shown to decline during normal pubertal progression in boys and girls, further suggesting its major inhibitory influence on pubertal timing (Hagen et al., 2015; Busch et al., 2016) .
Epigenetic basis of pubertal disorders: facts and open questions
In addition to genetic determinants, epigenetic mechanisms have been recently suggested to play an important role in the control of puberty, as deduced from studies in experimental models. Elucidation of such mechanisms is still at its infancy, and hence, its pathophysiological implications in terms of perturbations of puberty (especially in humans) are yet to be fully characterized. Based on pre-clinical observations, such epigenetic regulatory mechanisms might be ideally suited to transmit environmental influences to puberty-controlling networks, especially those occurring at critical developmental periods, as the epigenome is known to be especially sensitive during key maturational windows, such as gestation, early postnatal life and puberty (Dolinoy et al., 2007) . Among the environmental cues, nutritional signals are likely to play a determinant role, including the impact of early nutritional states. This is well illustrated by studies of perinatal overfeeding in rodents, in which a persistent increase in body weight is associated with durable changes in the methylation status of the POMC gene in the hypothalamus (as source of anorectic peptides, such as α-MSH); POMC promoter hyper-methylation was likely responsible for the refractoriness to the feeding-suppressing actions of leptin and insulin in this model of early onset obesity (Plagemann et al., 2009) . Interestingly, such a model has been associated to earlier puberty in rodents ; however, the eventual contribution of epigenetic changes to such pubertal phenotype remains unexplored. Similarly, conditions of obesity due to a HFD have been shown to impact epigenetic mechanisms involved in the hypothalamic control of food intake, resulting in deregulation of key neuroendocrine axes (e.g. thyroid) and metabolic homeostasis (Kohno et al., 2014) . Postnatal HFD exposure has been reported to induce demethylation of leptin promoter, causing an increase in leptin levels that may contribute to alterations in the timing of puberty associated to early-onset obesity (Shen et al., 2014) . In the same vein, high-throughput screening of hypothalamic changes of miRNA profiles in conditions of caloric restriction and HFD allowed us to identify alterations in specific miRNA signatures, including among others, let7a, miR-132, miR-145 and miR-200a (Sangiao-Alvarellos et al., 2014) , which have been associated with the control of puberty and/or the HPG axis. The above analyses, however, were conducted in adult animals; the specific contribution of such changes in hypothalamic miRNAs to alterations of puberty linked to metabolic stress needs additional investigation.
Despite this suggestive evidence, the clinical data connecting epigenetic alterations and pubertal disorders remains very scarce. In this context, a recent study has shown that CYP19A1 (aromatase) promoter is hypo-methylated in obese girls, which might lead to increased estrogen synthesis and early puberty (Stueve et al., 2014) .
In addition, Temple syndrome has been described as a condition caused by the isolated hypo-methylation of the 14q32 imprinted DLK1/MEG3 region, which triggers a clear clinical phenotype, including, among other manifestations, pre-and post-natal growth retardation, premature puberty and obesity (Briggs et al., 2016) . The potential interplay of such deregulated methylation with the neuroendocrine mechanisms described in previous sections remains unknown.
From a translational point of view, it is important to stress that epigenetic modifications are usually endowed with considerable cell/ tissue-specificity. Hence, changes occurring in brain centers governing puberty may not directly translate into changes in peripheral, more accessible tissues. Nonetheless, a recent study has highlighted that phenotypic signs of pubertal maturation in healthy children are paralleled by changes in DNA methylation patterns in peripheral blood samples . Some methylation changes in specific gene regions (e.g. TRIP6 promoter) were associated with fluctuations of the encoded protein in key reproductive tissues, such as the testis, during pubertal maturation. Equally, changes in circulating miRNAs have been reported in prepubertal obese children (Prats-Puig et al., 2013) . Of note, the main goal of such a study was the identification of early predictors of development of obesity and its complications. In fact, no data have been reported to date on the potential pathophysiological role of deregulated patterns of circulating miRNAs in the origin of altered puberty associated with metabolic distress, including early onset obesity.
EDs and pubertal disorders: neuroendocrine connections
Another source of environmental influence on pubertal timing stems from the potential action of natural and synthetic compounds, globally termed endocrine disruptors, which by blocking or mimicking hormonal actions, can interfere with the normal development and/or function of numerous hormonal systems (Parent et al., 2015 Castellano and Tena-Sempere, 2016a,b) . Among those, the HPG axis has been shown to be specially vulnerable to a wide array of EDs, targeting sex steroid signaling and metabolism, whose exposure has been linked to the escalating incidence of reproductive disorders, ranging from genital malformations to sperm count decline, infertility and forms of gonadal (e.g. testicular) cancer. Experimental and clinical studies have documented the plausibility of the impact of EDs on pubertal maturation, both in humans and animal species (Parent et al., 2015 . As a worrying feature, endocrine systems in general, and the reproductive axis in particular, are highly sensitive to the organizing effects of endogenous hormones (e.g. sex steroids), and EDs acting during critical developmental windows (e.g. gestational or early postnatal periods) may persistently perturb these effects, with consequences that can manifest in a deferred manner much later in life (Parent et al., 2015 Castellano and Tena-Sempere, 2016a) . Furthermore, while the isolated impact of a single ED might be minimal or null at environmental doses, natural exposures normally occur as mixtures of (often, differently acting) EDs, which raises concerns about potential summation or even synergy among various compounds (Silva et al., 2002) .
Puberty, as endpoint of a complex developmental continuum under strong hormonal influences, is potentially sensitive to EDs, acting at early or peripubertal periods, and targeting the various levels of the HPG axis. Accordingly, numerous studies have addressed the potential impact of EDs on pubertal maturation and later fertility. As an illustrative example, considerable attention has been drawn by bisphenol A (BPA), which is used in the production of plastics polycarbonate and resins, present in some plastic bottles, metal can linings or microwave wraps. BPA has a high penetrating activity, being detected in the urine of 93% of the US population (Schug et al., 2011) . Experimental studies in rodents have documented the impact of BPA on pubertal timing, mostly in the female but also in the male. However, depending on the dose, time-window and route of administration, variable effects of BPA exposure on the age of puberty have been reported. While a predominant number of studies have demonstrated that BPA can induce earlier appearance of VO (Losa-Ward et al., 2012) , recent analyses have shown that very low doses of BPA may delay puberty onset, possibly by enhancement of central GABAergic signaling . Notably, in that study, higher doses of BPA evoked opposite effects, illustrating that the impact of BPA on the centers governing puberty onset occurs in a strict dose-dependent manner. It is worthy mentioning that neonatal BPA exposure causes alterations in hypothalamic Kiss1 expression at the time of puberty (Navarro et al., 2009) , therefore suggesting the potential contribution of deregulated Kiss1 pathways, likely in conjunction with alterations in other factors (e.g. the orphan receptor, Gpr151) in pubertal alterations induced by BPA. The mechanisms for the deferred and durable impact of BPA on puberty likely include alterations in the epigenetic machinery and methylation status of certain genes (Prusinski et al., 2016) . For instance, BPA exposure during pregnancy has been found to alter the expression levels of methyltransferases (DNMT1 and 2) in the offspring, leading to abnormal ER expression (Kundakovic et al., 2013) . Whether perturbed epigenetic control of Kiss1 or other puberty-controlling genes is induced by BPA (or other EDs) to cause pubertal alterations remains unexplored.
Conclusion and future directions
Our understanding of the neuroendocrine basis of the physiological control of puberty and its deviations has expanded astonishingly in recent years. While some of the general ideas formulated decades ago about the central mechanisms responsible for the awakening of the HPG axis during pubertal maturation remain conceptually valid (Prevot, 2015) , we have now learnt in great detail how puberty is controlled hierarchically by sets of transmitters and molecular mediators, which act in concert to timely activate GnRH neurosecretion, when favorable endogenous and environmental conditions concur. Identification of 'single players' in this scenario, such as kisspeptins, NKB and leptin, just to mention some relevant examples, is illustrative of the substantial advancement of this area of Biomedicine, but should not overshadow the importance of an holistic approach aiming to understand the overarching network of regulatory pathways, in which these and other factors operate as essential elements. Certainly, recent discoveries regarding the putative contribution of epigenetic mechanisms and non-coding RNAs in the cascade of regulatory events leading to puberty onset will influence future avenues of research in this field, as further efforts are anticipated, aiming to gain better understanding of how these mechanisms operate and which gene pathways are preferentially targeted and to elucidate how and when endogenous (e.g. metabolic) cues and environmental influences of pubertal maturation, specially nutritional influences, interplay with such epigenetic machinery.
These efforts, which are already ongoing, coincide with important technical advancements and international initiatives, directed towards the characterization of the genetic basis of normal pubertal maturation and extreme phenotypes of advanced or delayed/absent puberty. Predictably, systematic application of next-generation sequencing to well selected populations of patients with congenital HH or central precocious puberty will permit the identification of novel players in the neuroendocrine systems governing sexual brain differentiation and puberty onset. In parallel, development of novel pre-clinical models of perturbed puberty, e.g. using mouse genetics and/or exposure to metabolic, hormonal or chemical insults, together with the application of novel technologies for precise functional dissection of brain circuits, such as optogenetics and DREADDs, which allow timed activation or inhibition of selected neuronal populations, will be instrumental to gain a deeper mechanistic insight into the central systems responsible for the timing of puberty. We forecast that these collective efforts, which are grounded on the fertile research conducted in the field especially in the last decade, will result in groundbreaking conceptual advancements (and considerable excitement) in our understanding of the basis of puberty and the management of its deviations.
